Our flagship product, LumineticsCore™, is spotlighted in a recent article from one of our innovative customers, OSF HealthCare! The article highlights how our AI-powered diagnostic platform is revolutionizing early diagnosis of diabetic retinopathy within their organization.
“In the first six months of using [LumineticsCore] technology in OSF HealthCare offices, 28 out of 100 people with diabetes tested positive, with about a 2% false-positive rate. That’s 28% of patients with diabetes who would have been at risk of losing their vision in the future if not for the [exam] to detect it early.”